Recent Finacing
Recent Raise
AdoRx Therapeutics is an Edinburgh-based drug discovery company developing adenosine receptor antagonists to counter adenosine-mediated immunosuppression in the tumor microenvironment for cancer therapies.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
See the team members at AdoRx Therapeutics.